Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Objective This study reviewed the current state of machine learning (ML) research for the prediction of sports-related injuries. It aimed to chart the various approaches used and assess their efficacy ...

(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo Nordisk, the maker of the GLP-1 drug Ozempic, announced Monday that U.S.

(Reuters) -Outlook Therapeutics said on Thursday the U.S. health regulator has declined to approve its experimental drug to treat a type of eye condition, which causes blurred vision, sending its ...